Skip to main content
. 2014 Apr 9;145(1):73–82. doi: 10.1007/s10549-014-2933-7

Fig. 4.

Fig. 4

Survival curves for tamoxifen-treated patients, grouped according to tumoral CXCL10 expression in terms of local recurrence-free survival. All patient tumors are estrogen receptor positive. a Patients with moderate/high tumoral CXCL10 expression and b patients with no/low tumoral CXCL10 expression